Long COVID has exposed medicine's blind-spot
On Feb 23, 2021, the National Institutes of Health announced a new US$1·15 billion initiative to support research and resources for so-called long COVID.1 This is the culmination of a year that has seen more scientific attention, public commentary, and media coverage of chronic unexplained medical s...
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2021-08, Vol.21 (8), p.1062-1064 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1064 |
|---|---|
| container_issue | 8 |
| container_start_page | 1062 |
| container_title | The Lancet infectious diseases |
| container_volume | 21 |
| creator | Burke, Matthew J del Rio, Carlos |
| description | On Feb 23, 2021, the National Institutes of Health announced a new US$1·15 billion initiative to support research and resources for so-called long COVID.1 This is the culmination of a year that has seen more scientific attention, public commentary, and media coverage of chronic unexplained medical symptoms (either post-infectious or not) than arguably the past decade combined. [...]disruptions in brain and brain–body function that probably account for such symptoms cannot yet be reliably identified by conventional blood tests or brain scans. [...]a common denominator in this field is medical consultations largely based on diagnostic exclusion, in which the absence of further answers or direction for recovery can leave patients feeling dismissed and dissatisfied.4 Two broad possibilities exist to explain where long COVID might fit in this complex and controversial field. The content of this article is the opinion of the authors and does not necessarily represent the official views of the University of Toronto, Harvard Medical School, or Emory University School of Medicine (and their affiliated academic health-care centers). |
| doi_str_mv | 10.1016/S1473-3099(21)00333-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8213360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309921003339</els_id><sourcerecordid>2555938302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-a9f49737a7471d02e31f293b1579e6c7996e16b910d88c686f8ed703ee5158423</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1ERUrgI4BW4kArdcHjsdfrCwiFtkSK1AN_rtbGO9u62qyDvang2-MkbQS9cLJl_2bmzXuMvQL-DjhU77-C1FgiN-ZEwCnniFiaJ-w4P8tSSqWf7u57ZMKep3TLOWjg8hmboASFAtUxO1uE4bqYXf2Yfy5umlTQr3VI1BYrar3zA71NxbL3Q1umdRhfsKOu6RO9vD-n7PvF-bfZl3JxdTmffVqUTho1lo3ppNGoGy01tFwQQicMLkFpQ5XTxlQE1dIAb-vaVXXV1dRqjkQKVC0FTtmHfd_1ZpmFOBrG2PR2Hf2qib9taLz992fwN_Y63NlaAGLFc4OT-wYx_NxQGu3KJ0d93wwUNskKJbMDtRA6o28eobdhE4e8XqaUMlgj3ypSe8rFkFKk7iAGuN3mYXd52K3ZVoDd5WFNrnv99yaHqocAMvBxD1D2885TtMl5Gly2P5IbbRv8f0b8AWGOl1I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555938302</pqid></control><display><type>article</type><title>Long COVID has exposed medicine's blind-spot</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Burke, Matthew J ; del Rio, Carlos</creator><creatorcontrib>Burke, Matthew J ; del Rio, Carlos</creatorcontrib><description>On Feb 23, 2021, the National Institutes of Health announced a new US$1·15 billion initiative to support research and resources for so-called long COVID.1 This is the culmination of a year that has seen more scientific attention, public commentary, and media coverage of chronic unexplained medical symptoms (either post-infectious or not) than arguably the past decade combined. [...]disruptions in brain and brain–body function that probably account for such symptoms cannot yet be reliably identified by conventional blood tests or brain scans. [...]a common denominator in this field is medical consultations largely based on diagnostic exclusion, in which the absence of further answers or direction for recovery can leave patients feeling dismissed and dissatisfied.4 Two broad possibilities exist to explain where long COVID might fit in this complex and controversial field. The content of this article is the opinion of the authors and does not necessarily represent the official views of the University of Toronto, Harvard Medical School, or Emory University School of Medicine (and their affiliated academic health-care centers).</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(21)00333-9</identifier><identifier>PMID: 34153235</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Brain ; Brain research ; Comment ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - epidemiology ; COVID-19 - therapy ; Humans ; Infections ; Infectious diseases ; Long COVID ; Medicine ; Pandemics ; Physiology ; Post-Acute COVID-19 Syndrome ; SARS-CoV-2 - physiology ; Severe acute respiratory syndrome coronavirus 2 ; Symptom Assessment</subject><ispartof>The Lancet infectious diseases, 2021-08, Vol.21 (8), p.1062-1064</ispartof><rights>2021 Elsevier Ltd</rights><rights>2021. Elsevier Ltd</rights><rights>2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-a9f49737a7471d02e31f293b1579e6c7996e16b910d88c686f8ed703ee5158423</citedby><cites>FETCH-LOGICAL-c495t-a9f49737a7471d02e31f293b1579e6c7996e16b910d88c686f8ed703ee5158423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1473309921003339$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34153235$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burke, Matthew J</creatorcontrib><creatorcontrib>del Rio, Carlos</creatorcontrib><title>Long COVID has exposed medicine's blind-spot</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>On Feb 23, 2021, the National Institutes of Health announced a new US$1·15 billion initiative to support research and resources for so-called long COVID.1 This is the culmination of a year that has seen more scientific attention, public commentary, and media coverage of chronic unexplained medical symptoms (either post-infectious or not) than arguably the past decade combined. [...]disruptions in brain and brain–body function that probably account for such symptoms cannot yet be reliably identified by conventional blood tests or brain scans. [...]a common denominator in this field is medical consultations largely based on diagnostic exclusion, in which the absence of further answers or direction for recovery can leave patients feeling dismissed and dissatisfied.4 Two broad possibilities exist to explain where long COVID might fit in this complex and controversial field. The content of this article is the opinion of the authors and does not necessarily represent the official views of the University of Toronto, Harvard Medical School, or Emory University School of Medicine (and their affiliated academic health-care centers).</description><subject>Brain</subject><subject>Brain research</subject><subject>Comment</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - therapy</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Long COVID</subject><subject>Medicine</subject><subject>Pandemics</subject><subject>Physiology</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>SARS-CoV-2 - physiology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Symptom Assessment</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU9vEzEQxS1ERUrgI4BW4kArdcHjsdfrCwiFtkSK1AN_rtbGO9u62qyDvang2-MkbQS9cLJl_2bmzXuMvQL-DjhU77-C1FgiN-ZEwCnniFiaJ-w4P8tSSqWf7u57ZMKep3TLOWjg8hmboASFAtUxO1uE4bqYXf2Yfy5umlTQr3VI1BYrar3zA71NxbL3Q1umdRhfsKOu6RO9vD-n7PvF-bfZl3JxdTmffVqUTho1lo3ppNGoGy01tFwQQicMLkFpQ5XTxlQE1dIAb-vaVXXV1dRqjkQKVC0FTtmHfd_1ZpmFOBrG2PR2Hf2qib9taLz992fwN_Y63NlaAGLFc4OT-wYx_NxQGu3KJ0d93wwUNskKJbMDtRA6o28eobdhE4e8XqaUMlgj3ypSe8rFkFKk7iAGuN3mYXd52K3ZVoDd5WFNrnv99yaHqocAMvBxD1D2885TtMl5Gly2P5IbbRv8f0b8AWGOl1I</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Burke, Matthew J</creator><creator>del Rio, Carlos</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210801</creationdate><title>Long COVID has exposed medicine's blind-spot</title><author>Burke, Matthew J ; del Rio, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-a9f49737a7471d02e31f293b1579e6c7996e16b910d88c686f8ed703ee5158423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Brain</topic><topic>Brain research</topic><topic>Comment</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - therapy</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Long COVID</topic><topic>Medicine</topic><topic>Pandemics</topic><topic>Physiology</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>SARS-CoV-2 - physiology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Symptom Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burke, Matthew J</creatorcontrib><creatorcontrib>del Rio, Carlos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burke, Matthew J</au><au>del Rio, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long COVID has exposed medicine's blind-spot</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>21</volume><issue>8</issue><spage>1062</spage><epage>1064</epage><pages>1062-1064</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>On Feb 23, 2021, the National Institutes of Health announced a new US$1·15 billion initiative to support research and resources for so-called long COVID.1 This is the culmination of a year that has seen more scientific attention, public commentary, and media coverage of chronic unexplained medical symptoms (either post-infectious or not) than arguably the past decade combined. [...]disruptions in brain and brain–body function that probably account for such symptoms cannot yet be reliably identified by conventional blood tests or brain scans. [...]a common denominator in this field is medical consultations largely based on diagnostic exclusion, in which the absence of further answers or direction for recovery can leave patients feeling dismissed and dissatisfied.4 Two broad possibilities exist to explain where long COVID might fit in this complex and controversial field. The content of this article is the opinion of the authors and does not necessarily represent the official views of the University of Toronto, Harvard Medical School, or Emory University School of Medicine (and their affiliated academic health-care centers).</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>34153235</pmid><doi>10.1016/S1473-3099(21)00333-9</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2021-08, Vol.21 (8), p.1062-1064 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8213360 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Brain Brain research Comment Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology COVID-19 - therapy Humans Infections Infectious diseases Long COVID Medicine Pandemics Physiology Post-Acute COVID-19 Syndrome SARS-CoV-2 - physiology Severe acute respiratory syndrome coronavirus 2 Symptom Assessment |
| title | Long COVID has exposed medicine's blind-spot |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A38%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long%20COVID%20has%20exposed%20medicine's%20blind-spot&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Burke,%20Matthew%20J&rft.date=2021-08-01&rft.volume=21&rft.issue=8&rft.spage=1062&rft.epage=1064&rft.pages=1062-1064&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(21)00333-9&rft_dat=%3Cproquest_pubme%3E2555938302%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555938302&rft_id=info:pmid/34153235&rft_els_id=S1473309921003339&rfr_iscdi=true |